Evidence map›Paper›PMID 26405597›Full record

ArticleOncoimmunology2015

Thioredoxin induces Tregs to generate an immunotolerant tumor microenvironment in metastatic melanoma.

Xiaogang Wang, Haisheng Dong, Qi Li, Yingxian Li, An Hong

Open access · goldAbstract read
In one paragraph

Article in Oncoimmunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. A metabolic perspective on nitric oxide function in melanoma.Biochimica et biophysica acta. Reviews on cancer · 2024
    Review
  8. Review
  9. Redox-Related Proteins in Melanoma Progression.Antioxidants (Basel, Switzerland) · 2022
    Article
  10. Article
  11. Article
  12. Review
  13. Cisplatin Resistance and Redox-Metabolic Vulnerability: A Second Alteration.International journal of molecular sciences · 2021
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Xiaogang WangDepartment of Cell Biology & Institute of Biomedicine; College of Life Science and Technology; Jinan University ; Guangzhou, China.
Haisheng DongState Key Laboratory of Space Medicine Fundamentals and Application; China Astronaut Research and Training Center ; Beijing, China.
Qi LiState Key Laboratory of Space Medicine Fundamentals and Application; China Astronaut Research and Training Center ; Beijing, China.
Yingxian LiState Key Laboratory of Space Medicine Fundamentals and Application; China Astronaut Research and Training Center ; Beijing, China.
An HongDepartment of Cell Biology & Institute of Biomedicine; College of Life Science and Technology; Jinan University ; Guangzhou, China.
Jinan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metastatic melanoma is a highly aggressive cancer that is very difficult to treat. Additionally, the antitumor immune reaction of melanoma is still unclear. Here we demonstrate an association between the expression and secretion of the antioxidant protein thioredoxin (TRX) and increasing tumor stage and metastasis in melanoma. To elucidate the role of TRX in melanoma, we assessed the correlation of TRX expression with different disease parameters in melanoma. We also examined the

Indexed as

antibodyimmunotolerantmelanomaregulatory T cellthioredoxinTregTRX

Identifiers

PMID26405597
PMCPMC4570104
OpenAlexW1576294450

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.